The Inhibitory HVEM-BTLA Pathway Counter Regulates Lymphotoxin β Receptor Signaling to Achieve Homeostasis of Dendritic Cells-Reference-Cited by-同舟云学术

The Inhibitory HVEM-BTLA Pathway Counter Regulates Lymphotoxin β Receptor Signaling to Achieve Homeostasis of Dendritic Cells

Published:2007-12-20 Issue:1 Volume:180 Page:238-248
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

De Trez Carl,Schneider Kirsten,Potter Karen,Droin Nathalie,Fulton James,Norris Paula S.,Ha Suk-won,Fu Yang-Xin,Murphy Theresa,Murphy Kenneth M.,Pfeffer Klaus,Benedict Chris A.,Ware Carl F.

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference60 articles.

1. Immunobiology of Dendritic Cells

2. CD4 and CD8 Expression by Dendritic Cell Subtypes in Mouse Thymus and Spleen

3. CD8α+ and CD8α− Subclasses of Dendritic Cells Direct the Development of Distinct T Helper Cells In Vivo

4. Dendritic cell subsets and the regulation of Th1/Th2 responses

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tertiary lymphoid structures in diseases: immune mechanisms and therapeutic advances;Signal Transduction and Targeted Therapy;2024-08-28

2. The Immune Checkpoint BTLA in Oral Cancer: Expression Analysis and Its Correlation to Other Immune Modulators;International Journal of Molecular Sciences;2024-06-15

3. BTLA biology in cancer: from bench discoveries to clinical potentials;Biomarker Research;2024-01-17

4. The benefits of clustering in TNF receptor superfamily signaling;Frontiers in Immunology;2023-08-17

5. The role of the BTLA-HVEM complex in the pathogenesis of autoimmune diseases;Cellular Immunology;2022-06